Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AMFRESH and EQT expect to close the acquisition of IFG by SNFL in the coming…
The positive verdict of the arbitration process initiated by a third party trying to block the deal On July, 11th the arbitrator assigned to decide on the matter rejected all the claims made by Jack Pandol, allowing the transaction to proceed.SNFL expects to close the transaction in the coming weeks.As Alvaro Muñoz,AMFRESHCEO, points out, “our entire team and partners are proud to be able to move forward with the green light of the arbitration. This is the beginning of a...
Nasdaq GlobeNewswire
12/07/2023
SKF divests coolant pumps operations
Thomas Fröst, President, Independent & Emerging Business, at SKF, says: "We are pleased to sell Spandau Pumpen to EBARA CORPORATION, a dedicated pump manufacturer that will be able to continue to develop this business. The divestment is another example of the ongoing pruning of our portfolio, which is an important part of our strategy." Thomas Fröst, President, Independent & Emerging Business, at SKF, says: "We are pleased to sell Spandau Pumpen to EBARA CORPORATION, a…
PR Newswire
12/07/2023
Immunovia to Significantly Restructure to Focus Resources on its Next-Generation…
Immunovia's strategic decision to focus on its next generation assay will result in significant layoffs in both Sweden and the United States in multiple functions. Importantly, the staffing reductions and the elimination of other operating expenses will lower the company's cash burn rate and extend the Company's cash reserves well into 2024. Immunovia's strategic decision to focus on its next generation assay will result in significant layoffs in bothSwedenandthe United Statesin...
PR Newswire
12/07/2023
Race executes agreement with Ardena for GMP manufacturing of RC220
The partnership strengthens Race's existing manufacturing programs by serving as a primary source for EU compliant supplies of RC220 required for EU clinical studies. It also provides a backup source for US and Australian clinical programs. The partnership strengthens Race's existing manufacturing programs by serving as a primary source for EU compliant supplies of RC220 required for EU clinical studies. It also provides a backup source for US and Australian clinical programs. CEO and...
PR Newswire
12/07/2023
XNK Therapeutics one of three winners of Business Sweden's Catalyst program 2023
Catalyst is a scale-up program for Sweden's most innovative and promising companies and is arranged by Business Sweden. Candidates that make it through the selection process gain a powerful steppingstone towards international growth, including tailored commercialization support, advice, and coaching in a chosen market by Business Sweden. Catalyst is a scale-up program forSweden'smost innovative and promising companies and is arranged by Business Sweden. Candidates that make it through the...
PR Newswire
12/07/2023
Kinarus Therapeutics Announces Personnel Change
Basel, Switzerland, July 12 , 2023– Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and ophthalmic diseases, announced that its interim-CFO, Mr Subhasis Roy, who worked as a consultant for the company, is leaving to pursue other opportunities. Dr Hari Kumar, Chairman of the Board of Kinarus Therapeutics Holding AG, commented: “We would like to thank Subhasis for his invaluable...
Nasdaq GlobeNewswire
12/07/2023
Latest data on lecanemab to be presented at Alzheimer's Association…
Wednesday, July 19, 2023 Session Time: 11:15 - 12:30 AAIC ASK Session (Q&A): 13:00 Amyloid Reduction and Evidence of Downstream Biomarker Modification Monday, July 17, 2023 Session Time: 14:15 - 15:30 Session Time: 8:00 - 8:45 Session Time: 8:00 - 8:45 Session Time: 8:00 - 9:15 Poster Session Time: 8:45 - 16:15 Eisai serves as the lead of lecanemab development and regulatory submissions globally with both Eisai and...
PR Newswire
12/07/2023
Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application…
Globally, renal carcinoma is the third most common type of malignancy in the urinary system, and RCC accounts for 80%-90% of all cases. According to data published in the Chinese Medical Journal, in 2022, there were approximately 77,000 new cases of renal carcinoma and 46,000 deaths due to this disease in China. Approximately one-third of the renal carcinoma patients had distant metastasis at initial diagnosis, while 20%-50% of the patients with localized tumors developed distant metastases...
Nasdaq GlobeNewswire
12/07/2023
Statistics on Hair Wigs and Extensions Market Size & Share Worth Over USD 12.25…
The report delves deeper into several crucial aspects of the global hair wigs and extensions market. It includes a detailed discussion of existing growth factors and restraints. Future growth opportunities and challenges that impact the hair wigs and extensions industry are comprehensively addressed in the report. The report delves deeper into several crucial aspects of the global hair wigs and extensions market. It includes a detailed discussion of existing growth factors and restraints...
PR Newswire
11/07/2023
Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies…
Key Takeaways from the Sickle Cell Disease Competitive Landscape Report Key Takeaways from the Sickle Cell Disease Competitive Landscape Report Request a sample and discover the recent advances in sickle cell disease treatment drugs @Sickle Cell Disease Competitive Landscape Report Sickle Cell Disease Overview Sickle cell disease is a group of inherited red blood cell diseases that affect hemoglobin, the protein that transports oxygen throughout the body. Red blood cells in...
PR Newswire
11/07/2023
Metabolomics Market Worth $5.33 Billion by 2028, Growing at a CAGR of 12.84% |…
Browse In-Depth TOC on Metabolomics Market 134 – Tables 119 – Charts 305 – Pages Browse In-Depth TOC on Metabolomics Market 134 – Tables 119 – Charts 305 – Pages Metabolomics is a rapidly growing field of research that revolutionizes understanding of food safety and quality control. Analyzing metabolites in food makes it possible to detect potential contaminants, determine the nutritional quality of food, and identify and quantify the flavor and aroma compounds in food...
PR Newswire
11/07/2023
Clinical Trial Supplies Market to be Worth $3.4 Billion by 2030: Grand View…
Read full market research report, "Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report, " Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By…
PR Newswire
11/07/2023
Lectra launches VectorFashion iX2 and VectorFashion Q2, a new generation of…
In fashion, the current trend is towards capsule collections and the constant renewal of products. Manufacturers therefore have to produce smaller volumes of the same design and the number of orders to process and materials to cut is increasing. VectorFashion iX2 and VectorFashion Q2 allow manufacturers to cut variable volumes in an agile manner, in all types of materials. In fashion, the current trend is towards capsule collections and the constant renewal of products. Manufacturers…
PR Newswire
11/07/2023
First-half 2023 revenue of € 5.4 million (+75%)
Press release Ecully , July 11, 2023 – 6 p.m.SPINEWAY First-half 2023 revenue of €5.4 million (+75%)Continued ramp-up of Distimp productsStrong sales growth in EuropeIn thousands of eurosUnaudited data 20232022 % change2023/2022Q1 revenue2,399 1,342 +79%Q2 revenue3,033 1,770 +71% H1 revenue 5,4323,113+75% Spineway's total revenue for the first half of 2023 was €5.4 million, up 75% compared with...
Nasdaq GlobeNewswire
11/07/2023
IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2023
Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1103/07/2023FR0010259150301110.31AQEUIPSEN549300M6SGDPB4Z94P1103/07/2023...
Nasdaq GlobeNewswire
11/07/2023
Remote Patient Monitoring Devices And Equipment Market Forecast 2023-2027…
The anticipated lack of competent healthcare personnel (doctors and nurses) will drive the remote patient monitoring devices and equipment market. As the number of patients with chronic conditions grows, it becomes more difficult to monitor them due to operational time and cost constraints. The growing number of chronic disease patients, the increased demand for monitoring, and the expected shortage of nurses will all contribute to the rapid rise of remote patient monitoring systems and…
PR Newswire
11/07/2023
Next-Generation Sequencing Informatics Market Projected to Achieve US$ 3.2…
Next-generation sequencing informatics (NGS) tool has changed the genomic research by allowing scientist to sequence whole genome. These new advanced NGS technology has made the RNA sequencing and genome cost-effective and thus used as a tool for various research applications. Next-generation sequencing informatics (NGS) tool has changed the genomic research by allowing scientist to sequence whole genome. These new advanced NGS technology has made the RNA sequencing and genome cost-effective...
PR Newswire
11/07/2023
Clinical Chemistry Analyzers Market worth $16.5 billion | MarketsandMarkets
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144027310 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144027310 Browse in-depth TOC on "Clinical Chemistry Analyzers Market"120 - Tables35 - Figures151 - Pages Clinical Chemistry Analyzers Market Scope: Reagents segment accounted for the largest share of the clinical chemistry analyzers market, by product segment, in 2022 ...
PR Newswire
11/07/2023
Osteotec expands international presence with new offices in Ireland and Sweden
Located in Blanchardstown Corporate Park in Dublin, Osteotec's new division allows closer alignment with the innovation-led medtech ecosystem in Ireland. Located in Blanchardstown Corporate Park inDublin, Osteotec's new division allows closer alignment with the innovation-led medtech ecosystem in Ireland. The simultaneous launch of a base of operations in Malmö will see the business enter a Nordic medical device market with an appetite for high quality, niche orthopaedic and implantable...
PR Newswire
11/07/2023
Transactions in connection with share buy-back program
Company announcement no. 34 - 2311 July 2023 Transactions in connection with share buy-back program On 8 May 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 17 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
11/07/2023
Healthcare Data Analytics Market size worth $ 122.20 Billion, Globally, by 2030…
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=60349 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=60349 Browse in-depth TOCon" Healthcare Data Analytics Market " 202 - Pages 126 – Tables 37 – Figures Healthcare Data Analytics Market Poised for Growth, Driven by Key Factors and Leading Players The healthcare data analytics market is on the brink of significant expansion, fueled by the crucial...
PR Newswire
11/07/2023
Peptide Synthesis Market worth $859 million | MarketsandMarkets
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365 Browse in-depth TOC on "Peptide Synthesis Market"238 - Tables41 - Figures257 - Pages Peptide Synthesis Market Scope: The reagents segment accounted for the largest share of the product & service segment in the peptide synthesis market in 2022. Based on...
PR Newswire
11/07/2023
Bipolar Disorder Market size worth $ 6.27 Billion, Globally, by 2030 at 2% CAGR…
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=33465 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=33465 Browse in-depth TOCon" Bipolar Disorder Market " 202 - Pages 126 – Tables 37 – Figures Global Bipolar Disorder Market: Increased Awareness and Technological Advancements Drive Market Growth The global Bipolar Disorder market is experiencing significant growth, driven by increased awareness,...
PR Newswire
11/07/2023
Skyelarke furthers its mission to break down barriers to clinical trial…
In addition to increased patient payment choice, SkyePay has also developed an API framework, soon to be released, which will allow IRT, EDC or ePRO integration, streamlining the payment process for patients, whilst reducing burden on Sites. In addition to increased patient payment choice, SkyePay has also developed an API framework, soon to be released, which will allow IRT, EDC or ePRO integration, streamlining the payment process for patients, whilst reducing burden on Sites…
PR Newswire
11/07/2023
Altri Comunicati